ASCL2 is a key regulator of the proliferation–differentiation equilibrium in the esophageal epithelium
Biology Open · 2024
DOI: 10.1242/bio.059919 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biology Open, 2024. Verfasst von Maude Hamilton und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke J1E4K8, Canada. Hauptthemen laut MEDLINE: Epidermis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CIHR, Natural Sciences and Engineering Research Council of Canada, Canadian Institutes of Health Research.
Abstract (Originalsprache)
The esophagus is protected from the hostile environment by a stratified epithelium, which renews rapidly. Homeostasis of this epithelium is ensured by a rare population of stem cells in the basal layer: Keratin 15+ (Krt15+) cells. However, little is known about the molecular mechanisms regulating their distinct features, namely self-renewal, potency and epithelial regeneration. Achaete-scute family BHLH transcription factor 2 (ASCL2) is strongly upregulated in Krt15+ stem cells and is known to contribute to stem cell maintenance in other tissues. Herein, we investigated the role of ASCL2 in maintaining homeostasis under normal and stress conditions in the esophageal epithelium. ASCL2 overexpression severely dysregulated cell differentiation and cell fate. Proliferation was also reduced due potentially to a blockage in the G1 phase of the cell cycle or an induction of quiescence. Mass spectrometry analysis confirmed alterations in several proteins associated with differentiation and the cell cycle. In addition, overexpression of ASCL2 enhanced resistance to radiation and chemotherapeutic drugs. Overall, these results denote the role of ASCL2 as a key regulator of the proliferation-differentiation equilibrium in the esophageal epithelium.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Immunology and Cell Biology, Faculty of Medicine and Health Sciences, Université de Sherbrooke, Sherbrooke J1E4K8, Canada.
- Centre de Recherche du Centre Hospitalier de l'Université de Sherbrooke (CRCHUS), Sherbrooke J1E4K8, Canada.
- Institut de Recherche sur le Cancer de l'Université de Sherbrooke (IRCUS), Sherbrooke J1E4K8, Canada.
- Université Paris Cité, Magistère Européen de génétique, Paris 75006, France.
ORCID-Profile: Véronique Giroux
Förderung
- CIHR
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
- Canada Research Chairs
- Centre de Recherche en Inflammation et Oncologie Digestive de l'Université de Sherbrooke
- Université de Sherbrooke Fondation De Sève
- Fonds de Recherche du Québec - Santé
- TRIANGLE Canada
Zitieren
APA
Hamilton, M., Mars, Z., Sedeuil, M., Rolland, M., Jean, D., Boudreau, F., & Giroux, V. (2024). ASCL2 is a key regulator of the proliferation–differentiation equilibrium in the esophageal epithelium. Biology Open. https://doi.org/10.1242/bio.059919
Vancouver
Hamilton M, Mars Z, Sedeuil M, Rolland M, Jean D, Boudreau F, et al. ASCL2 is a key regulator of the proliferation–differentiation equilibrium in the esophageal epithelium. Biology Open. 2024. doi:10.1242/bio.059919
BibTeX
@article{Hamilton2024,
author = {Hamilton, Maude and Mars, Zoéline and Sedeuil, Molly and Rolland, Marjorie and Jean, Dominique and Boudreau, François and Giroux, Véronique},
title = {ASCL2 is a key regulator of the proliferation–differentiation equilibrium in the esophageal epithelium},
journal = {Biology Open},
year = {2024},
doi = {10.1242/bio.059919}
}
EUVIMED